Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of localized scleroderma patients

From: Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) adapted for use in adult patients: report from an initial validation study

Variable No SD Range
Females: Males 33:7   
Variables Mean SD Range
Age (in years) 49.05 18.34 19–81
Age at disease onset (in years) 42.43 19.37 4–75
Duration of disease (in years) 6.63 8.31 0,3–30
mLoSSI 7.15 7.21 0–29
LoSDI 10.43 9.82 0–52
PhysGA-A 31.35 21.58 0–76
PhysGA-D 39.2 15.42 0–88
PtGA-S 42.48 31.42 0–100
PtGA-D 47.63 26.83 0–100
Variables No. of patients Percent  
Active disease 35 87.5  
 Without remission 26 65  
 Reccurent disease 1st relapse 6 15  
 Reccurent disease 2nd relapse 3 7.5  
Inactive disease 5 12.5  
Subtypes
 Plaque 18 45  
 Atrophoderma of Pasini and Pierini 8 20  
 Generalized 7 17.5  
 Mixed 4 10  
 Linear 3 7.5  
Musculoskeletal manifestations 3 7.5  
Comorbid medical conditions 25 62.5  
 Hypertensio arterialis 9 22.5  
 Diabetes type 2 5 12.5  
 Gastroesophageal reflux 3 7.5  
 Hashimoto disease 2 5  
 Hand eczema 2 5  
 Rheumatoid arthritis 2 5  
 Other 5 12.5  
  1. SD standard deviation, mLoSSI modified Localized Scleroderma Skin Severity Index, LoSDI Localized Scleroderma Damage Index, PhysGA-A physician global assessment of disease activity, PhysGA-D physician global assessment of disease damage, PtGA-S patient global assessment of disease severity, PtGA-D patient global assessment of disease damage